In a patient with a suspected infected iliac stent, should vancomycin be discontinued and replaced with IV meropenem (with daptomycin added if MRSA is a concern), obtain immediate blood cultures and repeat them in 24–48 hours, and order urgent contrast‑enhanced CT angiography of the abdomen/pelvis to evaluate the stent?

Discontinue Vancomycin and Switch to IV Meropenem with Daptomycin for Suspected Infected Iliac Stent

Yes, discontinue vancomycin and switch to IV meropenem with daptomycin added empirically for MRSA coverage, obtain immediate blood cultures and repeat them in 24–48 hours, and order urgent contrast-enhanced CT angiography (CTA) of the abdomen/pelvis to evaluate the stent.

Rationale for Antibiotic Switch

Why Discontinue Vancomycin

Multiple guidelines strongly discourage continued empirical vancomycin use when cultures remain negative for beta-lactam-resistant gram-positive organisms 1. In the context of a suspected vascular device infection, vancomycin has significant limitations:

• Poor tissue penetration into biofilm-associated infections on prosthetic materials
• Nephrotoxicity risk that complicates prolonged therapy 2
• Target attainment challenges, particularly with MIC values >1 mg/L 3, 2
• Guidelines explicitly state vancomycin should be discontinued after 2-3 days if susceptible bacteria are not recovered 4

Why Meropenem as Primary Agent

For suspected infected vascular stents, broad-spectrum coverage is essential because these infections are frequently polymicrobial 5. Meropenem provides:

• Excellent gram-negative coverage including Pseudomonas aeruginosa, which commonly infects vascular devices 6, 7
• Activity against many gram-positive organisms including some streptococci
• Superior biofilm penetration compared to vancomycin
• FDA-approved dosing: 1-2 grams IV every 8 hours 8

The literature on infected iliac stents demonstrates that Staphylococcus aureus (including MRSA) is the most common pathogen 9, 10, 11, 12, 13, but gram-negative organisms and polymicrobial infections occur frequently enough to warrant empiric broad-spectrum coverage 5.

Why Add Daptomycin for MRSA Coverage

Daptomycin should be added empirically rather than continuing vancomycin because:

• Superior efficacy for MRSA bacteremia and device-related infections 2
• Better biofilm penetration on prosthetic materials 14
• Faster bactericidal activity compared to vancomycin 15
• Dosing: 6-10 mg/kg IV once daily for complicated infections 2, 14
• Guidelines recommend daptomycin for serious MRSA infections when vancomycin MIC >1 mg/L or clinical failure 3, 2

Recent evidence suggests daptomycin at higher doses (8-10 mg/kg) may be preferable for device-related MRSA infections 2, 14.

Blood Culture Strategy

Obtain at least 2 sets of blood cultures immediately before antibiotic changes:

• Draw one set peripherally and one through any existing central access if present 6
• Repeat blood cultures in 24-48 hours to document clearance or persistent bacteremia 2
• Persistent positive cultures despite appropriate antibiotics strongly suggest device infection requiring surgical intervention 6, 5

This approach follows IDSA catheter-related infection guidelines, which apply to all intravascular device infections 6.

Imaging: Urgent CT Angiography

Order contrast-enhanced CTA of abdomen/pelvis immediately because:

• CTA is the primary imaging modality for suspected intravascular device infections 5
• Identifies pseudoaneurysm formation, perivascular fluid collections, and vascular anatomy for surgical planning 5, 9, 10
• Can guide percutaneous aspiration of fluid collections for culture 5

Consider adding PET-CT if CTA is non-diagnostic or shows equivocal findings 5, 9, 10. PET-CT has proven instrumental in detecting metabolically active infection when anatomical imaging is inconclusive 9.

Critical Management Points

Surgical Consultation

Obtain urgent vascular surgery consultation because:

• Infected vascular stents have 22.9% mortality in non-coronary cases 10
• 83.3% of non-coronary stent infections require emergency surgery 10
• Medical therapy alone frequently fails due to biofilm formation 9, 10, 13
• Persistent bacteremia despite appropriate antibiotics mandates surgical intervention 5, 10

Duration of Antibiotic Therapy

If surgery is performed:

• Minimum 4-6 weeks IV antibiotics post-operatively 2
• Tailor therapy based on intraoperative cultures and sensitivities 5

If surgery is not feasible:

• Prolonged suppressive therapy may be required, though outcomes are poor 5, 10

Common Pitfalls to Avoid

1. Do not continue vancomycin empirically beyond 48-72 hours without documented MRSA 1, 4, 1
2. Do not rely on single blood culture - multiple sets are essential 1, 6
3. Do not delay imaging - early CTA is critical for diagnosis and surgical planning 5
4. Do not attempt medical management alone if bacteremia persists - this indicates biofilm infection requiring device removal 9, 10
5. Monitor for vancomycin-induced neutropenia if it was used for >7-10 days 16